Hochster H - Search Results

1

Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer.

Hochster H, Kettner E, Kroning H, Becker K, Lordick F, Ramanathan RK, Macdonald J, Hong S, John W, Schmoll HJ. Hochster H, et al. Clin Colorectal Cancer. 2005 Nov;5(4):257-62. doi: 10.3816/ccc.2005.n.036. Clin Colorectal Cancer. 2005. PMID: 16356302 Clinical Trial.

2

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

Green MD, Speyer JL, Hochster HS, Liebes LF, Dunleavy S, Widman T, Wernz JC, Blum RH, Spiegel RJ, Muggia FM. Green MD, et al. Among authors: hochster hs. Cancer Res. 1988 May 1;48(9):2574-8. Cancer Res. 1988. PMID: 3356017

3

Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer.

Hochster HS. Hochster HS. Semin Oncol. 1995 Apr;22(2 Suppl 5):55-9; discussion 59-60. Semin Oncol. 1995. PMID: 7740334 Review.

4

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al. Hochster H, et al. J Clin Oncol. 1994 Mar;12(3):553-9. doi: 10.1200/JCO.1994.12.3.553. J Clin Oncol. 1994. PMID: 8120553 Clinical Trial.

5

Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology Group.

Chang A, Hunt M, Parkinson DR, Hochster H, Smith TJ. Chang A, et al. Among authors: hochster h. Am J Clin Oncol. 1993 Apr;16(2):152-5. doi: 10.1097/00000421-199304000-00015. Am J Clin Oncol. 1993. PMID: 8452109 Clinical Trial.

6

A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer.

Vokes EE, Figlin R, Hochster H, Lotze M, Rybak ME. Vokes EE, et al. Among authors: hochster h. Cancer J Sci Am. 1998 Jan-Feb;4(1):46-51. Cancer J Sci Am. 1998. PMID: 9467046 Clinical Trial.

7

A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer.

Hochster H, Speyer JL, Mandeli JP, Runowicz C, Wadler S, Berk G, Wallach R, Holland JF. Hochster H, et al. Gynecol Oncol. 1999 Mar;72(3):292-7. doi: 10.1006/gyno.1998.5261. Gynecol Oncol. 1999. PMID: 10053098 Free article. Clinical Trial.

8

Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687).

Hochster H, Strawderman MH, Harris JE, Atkins MB, Oken M, Skeel RT, Jubelirer SJ, Parkinson D. Hochster H, et al. Anticancer Drugs. 1999 Feb;10(2):245-8. doi: 10.1097/00001813-199902000-00014. Anticancer Drugs. 1999. PMID: 10211556 Clinical Trial.

9

A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687).

Hochster H, Oratz R, Ettinger DS, Borden E. Hochster H, et al. Invest New Drugs. 1998-1999;16(3):259-63. doi: 10.1023/a:1006110431250. Invest New Drugs. 1998. PMID: 10360606 Clinical Trial.

10

Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group.

Hochster H, Wadler S, Runowicz C, Liebes L, Cohen H, Wallach R, Sorich J, Taubes B, Speyer J. Hochster H, et al. J Clin Oncol. 1999 Aug;17(8):2553-61. doi: 10.1200/JCO.1999.17.8.2553. J Clin Oncol. 1999. PMID: 10561322 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page